Skip to main content

Megan Lee Neely

Associate Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1105, 11033 Hock Plaza, Durham, NC 27705-3860

Overview


Survival Analysis; Longitudinal Analysis; Joint Modeling; Prediction Modeling and Metrics; Biomarkers; Applications in Pulmonology and Lung Transplant; Statistical Education

Current Appointments & Affiliations


Associate Professor of Biostatistics & Bioinformatics · 2024 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Member in the Duke Clinical Research Institute · 2011 - Present Duke Clinical Research Institute, Institutes and Centers

Recent Publications


Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.

Journal Article Lung · March 9, 2025 PURPOSE: We used data from the IPF-PRO Registry of patients with idiopathic pulmonary fibrosis (IPF) to identify characteristics that predicted survival for a further > 5 years. METHODS: Participants had IPF that was diagnosed or confirmed at the enrolling ... Full text Link to item Cite

Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.

Journal Article J Heart Lung Transplant · March 2025 BACKGROUND: Few tools exist for the early identification of patients at risk for chronic lung allograft dysfunction (CLAD). We previously showed hyaluronan (HA), a matrix molecule that regulates lung inflammation and fibrosis, accumulates in bronchoalveola ... Full text Link to item Cite

Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.

Journal Article Ann Am Thorac Soc · March 2025 Rationale: Although exposure to air pollution is a known risk factor for adverse pulmonary outcomes, its impact in individuals with idiopathic pulmonary fibrosis (IPF) is less well understood. Objectives: To investigate the effects of long-term exposure to ... Full text Link to item Cite
View All Publications

Recent Grants


Lung Transplant Clinical Trial Network (LT-CTN)

ResearchStatistical Investigator · Awarded by National Institutes of Health · 2021 - 2028

Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)

ResearchCo-Mentor · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2028

Lung Transplant Consortium - Data Coordinating Center

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2022 - 2027

View All Grants

Education, Training & Certifications


North Carolina State University · 2011 Ph.D.